All attending UK organisations

UK companies attending Biotech Showcase and other events that we are aware of

(Click here to search profiles of our attending member companies):
Astex Pharmaceuticals, Barrington James, bit.bio, Intract Pharma, Scendea, Sphere Fluidics

Biotech Showcase
4BIO Capital, Accession Therapeutics, Adaptimmune, AilseBio, Albion VC, ALSA Ventures, Antiverse, Arrowfield Capital, Astex Pharmaceuticals, Avata Biosciences, Backed VC, Bi -Path Bio, Bioarchitech, Biorelate, Black Opal Ventures, Blackhawk Innovation, Brandon Capital, Calvine Partners , Cancer Research Horizons, Catalytic Impact Foundation, Cell and Gene Therapy Catapult, DeBere Partners, Deliver Biosciences, Eisai Co, Ellipses Pharma, Enhanc3d Genomics, Epidarex Capital, Esperante Ventures, Evariste, Evox Therapeutics, Exogene, Future Planet Capital, GHO Capital, Global Brain, H Tree Capital, Harness Therapeutics, HCVC, ICG Life Sciences, ICG Capital, ImmuPharma PLC, Imperial College London, Intract Pharma, Jiahao Huang, Johnson & Johnson Innovation -JJDC, KELES Digital Health, Kerna Ventures, Laverock Therapeutics, LongGame Venture Capital, Manta Ray, MassMutual Ventures, Meltwind, Microplate Dx, MitoRx Therapeutics, Momentum Biotech, MultiOmic Health, Nanograb, NanoSyrinx, New Science Fund, o2h Ventures, Oppilotech, Orbit Discovery, Outrun Therapeutics, Oxford Medical Products, OxSonics Therapeutics, Persica Pharmaceuticals, Phaim Pharma, PharmEnable Therapeutics, Pictura Bio, Plurify, PNAS Therapeutics, Pneumagen, Receptor.AI, Rosetta Capital, Scendea, ScienceMachine, Sireau Labs, SolasCure, Spirea, Tay Therapeutics, TCP Health Ventures, Tiziana Life Sciences, Treos Bio, U -Ploid Biotechnologies, University of Glasgow, VasoDynamics, Veirulence, Yakumed, Yaqrit

RESI JPM
Abingdon Health, ALSA Ventures, AlveoGene, ClotProtect Therapeutics, Combat Medical, Diosynvax, DLRC, Echopoint Medical Ltd (EML), Evariste, Exonate, Fieldfisher, Global Bio Fund (Jaya Ventures), Cancer Research Horizons , Ignota Labs, NanOptima, O2h Ventures, Outsee, Pleco Therapeutics, Plexaa, PolyAdvant, Rinri Therapeutics, Scendea, Sphere Fluidics, Tailor Bio, Tay Therapeutics, ZiO Health 

1st Annual BOIF
Albion VC, ALSA Ventures, AXA Investment Managers, Debere, J.P. Morgan Asset Management, LSV Capital Partners, Melio Bio, Momentum Biotech, New Science Fund, Nxera Pharma UK, Oxford Medical Products, re.Mind Capital, The Fulford Group.

8th Annual NIF
AlbionVC, ALSA Ventures, Arrowfield Capital, Autifony Therapeutics Limite, Avata Biosciences, Compass Pathways, Debere, Edison Group, Eli Lilly and Company, ImmunoBrain Inc., Intermediate Capital Group, Johnson & Johnson Innovation – JJDC, Inc., LSV Capital Partners, Momentum Biotech, Neurocentrx Pharma, New Science Fund, Nxera Pharma, ObserVa Capital, Pangea Botanica, Qiming Venture Partners, re.Mind Capital, RS PharmaServices, Serenatis Bio, The Fulford Group, UCB Ventures.